David Whitehorn

Summary

Affiliation: Nova Scotia
Country: Canada

Publications

  1. ncbi Neuromotor dysfunction in early psychosis
    David Whitehorn
    Nova Scotia Early Psychosis Program, Dartmouth, Canada
    Ann Clin Psychiatry 14:113-21. 2002
  2. ncbi Hospitalization in the first year of treatment for schizophrenia
    David Whitehorn
    Nova Scotia Early Psychosis Program, Dartmouth, Nova Scotia
    Can J Psychiatry 49:635-8. 2004
  3. doi An investigation of a possible relationship between olfactory identification deficits at first episode and four-year outcomes in patients with psychosis
    Kimberley P Good
    Nova Scotia Early Psychosis Program, Canada
    Schizophr Res 124:60-5. 2010
  4. ncbi Prolactin elevation with quetiapine
    Maria Alexiadis
    Am J Psychiatry 159:1608-9. 2002
  5. ncbi The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients
    Kimberley P Good
    Department of Psychiatry, Dalhousie University, Suite 9216 AJLB, 5909 Veterans Memorial Lane, Halifax, NS, Canada B3H 2E2
    Schizophr Res 68:11-9. 2004
  6. ncbi Quetiapine treatment in early psychosis: no evidence of cataracts
    David Whitehorn
    Schizophr Res 71:511-2. 2004
  7. ncbi Treatment of a first episode of psychotic illness with quetiapine: an analysis of 2 year outcomes
    Lili C Kopala
    Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
    Schizophr Res 81:29-39. 2006
  8. ncbi Olfactory identification deficits in first-episode psychosis may predict patients at risk for persistent negative and disorganized or cognitive symptoms
    Kimberley P Good
    Department of Psychiatry, Dalhousie University, Halifax, NS, Canada
    Am J Psychiatry 163:932-3. 2006

Detail Information

Publications8

  1. ncbi Neuromotor dysfunction in early psychosis
    David Whitehorn
    Nova Scotia Early Psychosis Program, Dartmouth, Canada
    Ann Clin Psychiatry 14:113-21. 2002
    ..Atypical antipsychotic agents can alleviate psychosis without inducing EPSS. Preexisting EPSS may be corrected...
  2. ncbi Hospitalization in the first year of treatment for schizophrenia
    David Whitehorn
    Nova Scotia Early Psychosis Program, Dartmouth, Nova Scotia
    Can J Psychiatry 49:635-8. 2004
    ..To determine the rates of hospitalization during the first year of treatment for schizophrenia, using an epidemiologic sample...
  3. doi An investigation of a possible relationship between olfactory identification deficits at first episode and four-year outcomes in patients with psychosis
    Kimberley P Good
    Nova Scotia Early Psychosis Program, Canada
    Schizophr Res 124:60-5. 2010
    ..In the current study, we examined whether patients with first episode psychosis who have olfactory identification deficits (microsmic) have poorer functional outcome than those whose olfactory status is normal (normosmic)...
  4. ncbi Prolactin elevation with quetiapine
    Maria Alexiadis
    Am J Psychiatry 159:1608-9. 2002
  5. ncbi The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients
    Kimberley P Good
    Department of Psychiatry, Dalhousie University, Suite 9216 AJLB, 5909 Veterans Memorial Lane, Halifax, NS, Canada B3H 2E2
    Schizophr Res 68:11-9. 2004
    ..However, the relationship between the clinically rated cognitive factor and performance-based cognitive test scores has not been thoroughly examined, particularly in patients who are early in the course of illness...
  6. ncbi Quetiapine treatment in early psychosis: no evidence of cataracts
    David Whitehorn
    Schizophr Res 71:511-2. 2004
  7. ncbi Treatment of a first episode of psychotic illness with quetiapine: an analysis of 2 year outcomes
    Lili C Kopala
    Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
    Schizophr Res 81:29-39. 2006
    ..The first episode of a psychotic disorder provides a unique opportunity to initiate optimal treatment but when a new medication becomes available, little data exist to guide the appropriate use in this population...
  8. ncbi Olfactory identification deficits in first-episode psychosis may predict patients at risk for persistent negative and disorganized or cognitive symptoms
    Kimberley P Good
    Department of Psychiatry, Dalhousie University, Halifax, NS, Canada
    Am J Psychiatry 163:932-3. 2006
    ..One-third of patients with a schizophrenia spectrum disorder have a measurable olfactory identification deficit at first examination. The authors studied the relationship of this deficit to symptom remission after 1 year of treatment...